EMA Withdrawn: Uprima (apomorphine hydrochloride) — Abbott Laboratories Ltd.

View source ↗

Summary

EMA has withdrawn Uprima (apomorphine hydrochloride) for erectile dysfunction (Abbott Laboratories Ltd.).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• Uprima (apomorphine hydrochloride)

Snippet

Status: Withdrawn. Therapeutic area: Erectile Dysfunction. MAH: Abbott Laboratories Ltd.. Decision date: 29/05/2006